Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
Altamira Therapeutics Ltd
CYTO
Healthcare
Altamira Therapeutics Ltd. is a Bermuda-based company engaged in developing ribonucleic acid (RNA)-based therapeutics for extrahepatic targets (OligoPhore/SemaPhore delivery platforms). The Company has two flagship short interfering (siRNA) programs in preclinical development beyond in vivo proof of concept: AM-401 for KRAS driven cancer and AM-411 for rheumatoid arthritis. The delivery...
platform is also suited for messenger RNA (mRNA) and other types of RNA therapeutics and is focused to be leveraged via out-licensing to pharma or biotech companies. The therapeutic objective for AM-401 is to slow down KRAS driven tumor cell growth and proliferation or to stop it altogether by delivering siRNA specifically inside tumor cells for gene knock down. AM-411 is a polyplex nanoparticle delivering siRNA to inflamed tissues to target the NF-kB signaling pathway, a critical regulator of immune and inflammatory responses. Like AM-401, the drug product is based on its OligoPhore technology.
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Bullboard (NDAQ:CYTO)
New Post
View:
Posts & Comments
Threaded Posts
Prev
1
2
3
4
5
6
7
8
9
10
Next
(57)
•••
Iseneschal
X
View Profile
View Bullboard History
Post by
Iseneschal
on Jan 29, 2024 2:39pm
CYTO....stay tuned for some Price Action...JMHO
Looks like Mr. M is getting all his "Ducks" in order Start the drumroll...currently at $1.94 bid....offered at $2.02
(57)
•••
Iseneschal
X
View Profile
View Bullboard History
Post by
Iseneschal
on Jan 24, 2024 11:45am
CYTO...no wonder there was a little pop & vol ; )
Altamira Therapeutics to Present at 3rd Annual mRNA-Based Therapeutics Summit 2024-01-08 05:47 ET - News Release HAMILTON, BERMUDA , Jan. 08, 2024 (GLOBE NEWSWIRE
...more
(0)
•••
PressRelease
X
View Profile
View Bullboard History
Post by
PressRelease
on Jan 08, 2024 8:47am
New Press Release - Altamira Therapeutics to Present at 3rd Annual mRNA-Based Therapeutics Summit
HAMILTON, BERMUDA , Jan. 08, 2024 (GLOBE NEWSWIRE) -- Altamira Therapeutics to Present at 3rd Annual mRNA-Based Therapeutics SummitAltamira’s two flagship programs, AM-401 and AM-411, designed for KRAS-driven cancer and rheumatoid arthritis, serve to demonstrate the technology’s capability to...
read article.
(0)
•••
PressRelease
X
View Profile
View Bullboard History
Post by
PressRelease
on Dec 29, 2023 8:47am
New Press Release - Altamira Therapeutics Regains Compliance with Nasdaq Minimum Bid Price Requirement
HAMILTON, BERMUDA, Dec. 29, 2023 (GLOBE NEWSWIRE) -- HAMILTON, BERMUDA, Dec. 29, 2023 -- Altamira Therapeutics Ltd. ("Altamira" or the "Company") (Nasdaq: CYTO), a company providing nanoparticle-based technology for efficient RNA delivery to extrahepatic targets, announced that it received a...
read article.
(57)
•••
Iseneschal
X
View Profile
View Bullboard History
Post by
Iseneschal
on Dec 21, 2023 3:31pm
CYTO.....Frontloaders offing the cheap stuff ; )
Don't be a bagholder
(57)
•••
Iseneschal
X
View Profile
View Bullboard History
Post by
Iseneschal
on Dec 21, 2023 2:08pm
CYTO....All u get is a 20 : 1 "haircut".......then the
" Tomahawk chop"......N.L.O.D Get used to it There is nothing good about this Train wreck
(57)
•••
Iseneschal
X
View Profile
View Bullboard History
Post by
Iseneschal
on Dec 13, 2023 11:12am
CYTO....hurry up and dye !
JMHO
(57)
•••
Iseneschal
X
View Profile
View Bullboard History
Post by
Iseneschal
on Dec 13, 2023 10:24am
CYTO.....case in point LoL
Now in PB mode right after N.H.O.D Up on low volume ....down on lower volume
(57)
•••
Iseneschal
X
View Profile
View Bullboard History
Post by
Iseneschal
on Dec 13, 2023 10:21am
CYTO..... pick ur spot LoL
This could be sub $4 or north of $10 in a heartbeat Too risky for me
(57)
•••
Iseneschal
X
View Profile
View Bullboard History
Post by
Iseneschal
on Dec 13, 2023 10:09am
CYTO....RS eff this a.m....very tight float
350,000 shs o/s No position....unfortunately ; )
(0)
•••
PressRelease
X
View Profile
View Bullboard History
Post by
PressRelease
on Dec 11, 2023 8:00am
New Press Release - Altamira Therapeutics Provides Investor and Business Update
HAMILTON, BERMUDA, Dec. 11, 2023 (GLOBE NEWSWIRE) -- Company hosts Investor and Business Update call on December 11 at 8:30 a.m. ETPartial spin-off of Bentrio® business first step in transition to become ‘pure play’ RNA delivery companyTransition expected to complete in 2024 through partnering of...
read article.
(61)
•••
Nibinator
X
View Profile
View Bullboard History
Post by
Nibinator
on Dec 06, 2023 3:17pm
Aller up on remet ca
Up up up up
(61)
•••
Nibinator
X
View Profile
View Bullboard History
Post by
Nibinator
on Dec 05, 2023 2:25pm
Boom
Live
(61)
•••
Nibinator
X
View Profile
View Bullboard History
Post by
Nibinator
on Dec 05, 2023 2:24pm
Phone call
(0)
•••
PressRelease
X
View Profile
View Bullboard History
Post by
PressRelease
on Dec 05, 2023 12:54pm
New Press Release - Altamira Therapeutics to Host Investor & Business Update Call on December 11th
HAMILTON, BERMUDA , Dec. 05, 2023 (GLOBE NEWSWIRE) -- HAMILTON, BERMUDA--December 5, 2023--Altamira Therapeutics Ltd. ("Altamira" or the "Company") (Nasdaq: CYTO), a company dedicated to developing therapeutics that address important unmet medical needs, announced today that it will host an...
read article.
Prev
1
2
3
4
5
6
7
8
9
10
Next
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
The Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Featured News Links
An Opportunity to Join Pulsar Helium on the Ground in Minnesota for a Historic Reservoir Flow Test
NOI Filed for Drill Program at Lithium/Uranium Project in Nevada
Silvercorp to Acquire Adventus for Implied Consideration of C$0.50 per Share
Meet one of the Strongest Contenders to Lead Canada’s Cannabis Market
Multiple High-Grade Gold Hits at the Tonopah Gold Project Including 90 Meters at 2.0 gpt Gold